GI50 (functional)
|
= 4.35 uM
|
Growth inhibitory activity was determined against A549/ATCC cancer cell line of non-small cell lung cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.35 uM
|
Growth inhibitory activity was determined against U-251 cancer cell line of CNS cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.35 uM
|
Growth inhibitory activity was determined against A549/ATCC cancer cell line of non-small cell lung cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.35 uM
|
Growth inhibitory activity was determined against U-251 cancer cell line of CNS cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.69 uM
|
Growth inhibitory activity was determined against HT-29 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.69 uM
|
Growth inhibitory activity was determined against LOX IMVI cancer cell line of melanoma
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.69 uM
|
Growth inhibitory activity was determined against HT-29 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.69 uM
|
Growth inhibitory activity was determined against LOX IMVI cancer cell line of melanoma
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.77 uM
|
Growth inhibitory activity was determined against HCC-2998 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.77 uM
|
Growth inhibitory activity was determined against HCC-2998 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.86 uM
|
Growth inhibitory activity was determined against LOX IMVI cancer cell line of melanoma
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.86 uM
|
Growth inhibitory activity was determined against LOX IMVI cancer cell line of melanoma
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.88 uM
|
Growth inhibitory activity was determined against OVCAR-8 cancer cell line of Ovarian cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 4.88 uM
|
Growth inhibitory activity was determined against OVCAR-8 cancer cell line of Ovarian cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.01 uM
|
Growth inhibitory activity was determined against SF-539 cancer cell line of CNS cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.01 uM
|
Growth inhibitory activity was determined against SF-539 cancer cell line of CNS cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.09 uM
|
Growth inhibitory activity was determined against A549/ATCC cancer cell line of non-small cell lung cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.09 uM
|
Growth inhibitory activity was determined against A549/ATCC cancer cell line of non-small cell lung cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.16 uM
|
Growth inhibitory activity was determined against BT-549 cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.16 uM
|
Growth inhibitory activity was determined against BT-549 cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.18 uM
|
Growth inhibitory activity was determined against HT-29 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.18 uM
|
Growth inhibitory activity was determined against HT-29 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.19 uM
|
Growth inhibitory activity was determined against OVCAR-3 cancer cell line of of Ovarian cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.19 uM
|
Growth inhibitory activity was determined against OVCAR-3 cancer cell line of of Ovarian cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.25 uM
|
Growth inhibitory activity was determined against OVCAR-3 cancer cell line of Ovarian cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.25 uM
|
Growth inhibitory activity was determined against OVCAR-3 cancer cell line of Ovarian cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.27 uM
|
Growth inhibitory activity was determined against NCI-H23 cancer cell line of non-small cell lung cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.27 uM
|
Growth inhibitory activity was determined against NCI-H23 cancer cell line of non-small cell lung cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.29 uM
|
Growth inhibitory activity was determined against COLO 205 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.29 uM
|
Growth inhibitory activity was determined against COLO 205 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.34 uM
|
Growth inhibitory activity was determined against NCI/ADR-RES cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.34 uM
|
Growth inhibitory activity was determined against NCI/ADR-RES cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.36 uM
|
Growth inhibitory activity was determined against HCC-2998 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.36 uM
|
Growth inhibitory activity was determined against HCC-2998 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.55 uM
|
Growth inhibitory activity was determined against COLO 205 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.55 uM
|
Growth inhibitory activity was determined against COLO 205 cancer cell line colon cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.85 uM
|
Growth inhibitory activity was determined against NCI-H23 cancer cell line of non-small cell lung cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 5.85 uM
|
Growth inhibitory activity was determined against NCI-H23 cancer cell line of non-small cell lung cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 6.05 uM
|
Growth inhibitory activity was determined against SN12C cancer cell line of Renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 6.05 uM
|
Growth inhibitory activity was determined against SN12C cancer cell line of Renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 6.2 uM
|
Growth inhibitory activity was determined against BT-549 cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 6.2 uM
|
Growth inhibitory activity was determined against BT-549 cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 6.46 uM
|
Growth inhibitory activity was determined against SN12C cancer cell line of renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 6.46 uM
|
Growth inhibitory activity was determined against SN12C cancer cell line of renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 6.69 uM
|
Growth inhibitory activity was determined against T-47D cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 6.69 uM
|
Growth inhibitory activity was determined against T-47D cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 6.88 uM
|
Growth inhibitory activity PC-3 cancer cell line of of Prostate cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 6.88 uM
|
Growth inhibitory activity PC-3 cancer cell line of of Prostate cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 7.04 uM
|
Growth inhibitory activity was determined against SK-MEL-5 cancer cell line of melanoma
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 7.04 uM
|
Growth inhibitory activity was determined against SK-MEL-5 cancer cell line of melanoma
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 7.15 uM
|
Growth inhibitory activity was determined against PC-3 cancer cell line of Prostate cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 7.15 uM
|
Growth inhibitory activity was determined against PC-3 cancer cell line of Prostate cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 7.18 uM
|
Growth inhibitory activity was determined against 786-0 cancer cell line of renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 7.18 uM
|
Growth inhibitory activity was determined against 786-0 cancer cell line of renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 7.71 uM
|
Growth inhibitory activity was determined against SK-MEL-5 cancer cell line of melanoma
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 7.71 uM
|
Growth inhibitory activity was determined against SK-MEL-5 cancer cell line of melanoma
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 8.02 uM
|
Growth inhibitory activity was determined against OVCAR-8 cancer cell line of of Ovarian cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 8.02 uM
|
Growth inhibitory activity was determined against OVCAR-8 cancer cell line of of Ovarian cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 8.2 uM
|
Growth inhibitory activity was determined against NCI/ADR-RES cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 8.2 uM
|
Growth inhibitory activity was determined against NCI/ADR-RES cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 8.45 uM
|
Growth inhibitory activity was determined against 786-0 cancer cell line of Renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 8.45000000000001 uM
|
Growth inhibitory activity was determined against 786-0 cancer cell line of Renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 8.74 uM
|
Growth inhibitory activity was determined against UO-31 cancer cell line of renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 8.74 uM
|
Growth inhibitory activity was determined against UO-31 cancer cell line of renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 9.27 uM
|
Growth inhibitory activity was determined against T-47D cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 9.27 uM
|
Growth inhibitory activity was determined against T-47D cancer cell line of Breast cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 9.97 uM
|
Growth inhibitory activity was determined against UO-31 cancer cell line of Renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 9.97 uM
|
Growth inhibitory activity was determined against UO-31 cancer cell line of Renal cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 10.8 uM
|
Growth inhibitory activity was determined against SF-539 cancer cell line of CNS cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
= 10.8 uM
|
Growth inhibitory activity was determined against SF-539 cancer cell line of CNS cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
> 25 uM
|
Growth inhibitory activity was determined against NCI-H522 cancer cell line of non-small cell lung cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
> 25 uM
|
Growth inhibitory activity was determined against SF-268 cancer cell line of CNS cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
> 25 uM
|
Growth inhibitory activity was determined against NCI-H522 cancer cell line of non-small cell lung cancer
|
ChEMBL.
|
11262093
|
GI50 (functional)
|
> 25 uM
|
Growth inhibitory activity was determined against SF-268 cancer cell line of CNS cancer
|
ChEMBL.
|
11262093
|
IC50 (binding)
|
= 1.9 uM
|
Inhibitory activity tested against cell division cycle 25A (assay using fluorescein diphosphate (FDP) as substrate)
|
ChEMBL.
|
11262093
|
IC50 (binding)
|
= 1.9 uM
|
Inhibitory activity tested against cell division cycle 25A (assay using fluorescein diphosphate (FDP) as substrate)
|
ChEMBL.
|
11262093
|
IC50 (binding)
|
= 2.2 uM
|
Inhibitory activity tested against cell division cycle 25A (assay using fluorescein diphosphate (FDP) as substrate)
|
ChEMBL.
|
11262093
|
IC50 (binding)
|
= 2.2 uM
|
Inhibitory activity tested against cell division cycle 25A (assay using fluorescein diphosphate (FDP) as substrate)
|
ChEMBL.
|
11262093
|
IC50 (binding)
|
= 8.6 uM
|
Inhibitory activity tested against human cell division cycle 45-like 2
|
ChEMBL.
|
11262093
|
IC50 (binding)
|
= 8.6 uM
|
Inhibitory activity tested against human cell division cycle 45-like 2
|
ChEMBL.
|
11262093
|
IC50 (binding)
|
= 9.1 uM
|
Inhibitory activity tested against Human CD45 Phosphatase (assay using fluorescein diphosphate (FDP) as substrate)
|
ChEMBL.
|
11262093
|
IC50 (binding)
|
= 9.1 uM
|
Inhibitory activity tested against Human CD45 Phosphatase (assay using fluorescein diphosphate (FDP) as substrate)
|
ChEMBL.
|
11262093
|